Examples of 'interferon-a' in a sentence
Meaning of "interferon-a"
interferon-a (noun) - A type of protein that plays a role in the immune response, often used in medical contexts to treat conditions such as viral infections
How to use "interferon-a" in a sentence
Basic
Advanced
interferon-a
Preferably the interferon used will be interferon-a.
A potentiated combination comprising a human interferon-a and glutathione or a precursor or inducer thereof.
A laboratory standard calibrated according to an international standard for interferon-a is applied.
Thus the interferon-a is generally administered parenterally, for example by injection, preferably subcutaneous injection.
Another cytokine with promise as an anti-cancer and antiviral agent is interferon-a.
Examples of human interferon-a of use with the present invention include those mentioned hereinbefore.
A liver biopsy was performed in all patients prior to the initiation of Interferon-a therapy.
No Interferon-a was detected in vehicle treated controls.
Current therapy for HCV infection include interferon-a and ribaviron in combination.
Then, the interferon-a concentration in the blood was analyzed using an ELISA kit.
Combination therapy of HCV with ribavirin and interferon-a currentlyrepresent the optimal therapy.
This immunosuppression is associated with excessive production of interferon-a and - Y.
A hybrid of TNF and interferon-a also has been found to possess anti-cancer activity.
In steroid-resistant patients, cytotoxic drugs such as hydroxyurea and Interferon-a are an alternative therapeutic approach.
Recombinant murine interferon-a was purchased from Life Technologies Inc.
See also
Current standard of care of HCV comprises combination therapy with pegylated interferon-a and ribavirin.
The samples are analyzed for interferon-a and for tumor necrosis factor-a by ELISA.
Interferon-a is a Type I interferon, a class which also includes the B and w interferons.
Combination therapy of HCV with ribavirin and interferon-a currently represent the optimal therapy.
Human interferon-a 2b was used as a positive control compound.
Combination therapy of HCV with ribavirin and interferon-a currently is the optimal therapy for HCV.
In another embodiment of the invention, the cytokine is interferon-a.
Combination of Histamine and Interferon-a Another enhancer of NK cell cytotoxicity is interferon-a.
A dry composition according to claim 7, wherein the active ingredient is interferon-a.
In a further embodiment, the interferon-a is administered for a period of up to 18 months.
In yet another embodiment, the cytotoxicity enhancing agent comprises interferon-a and interleukin-2.
However, interferon-a plays a crucial role in the innate immune response.
In particular, peptide fragments that have binding sites with interferon-a or interferon-Y receptors.
IL-2 and Interferon-a Both have been widely used in conjunction with chemotherapeutic agents.
Earlier investigations of the mechanism of action demonstrated the stimulation of interleukin-2 and interferon-a.
In nature they comprise p and y interferon, and the about 20 different interferon-a subtypes.
The purified poly ( ethylene glycol ) interferon conjugate and a sample of the native interferon-a 2b were evaluated.
Absence of inhibition of the effect of interferon-a on macrophages in the presence of Tat-toxoid,.
In specific embodiments, the recombinant Type 1 interferon protein is an interferon-B or an interferon-a.
Currently, interferon-Y and one subclass of interferon-a are the only type II interferons.
In certain embodiments, the recombinant Type 1 interferon protein is an interferon-B or an interferon-a.
A combination according to Claim 3, wherein the natural human interferon-a is human lymphoblastoid interferon.
Interferon-a is designated IFN.
Use according to Claim 7, wherein the human interferon-a is recombinant.
Interferon-a ( IFN-a ) has been employed to treat leukemias, myeloma, and renal cell carcinomas.
A combination according to Claim 1, wherein the human interferon-a is recombinant.
Interferon-a ( IFN-a ) has previously been investigated with classical chemotherapeutics, ie . cisplatin, vinclesine and dacarbacine.
A combination according to Claim 1, wherein the human interferon-a is natural.
Current therapies for hepatitis C include interferon-a ( INFa ) and combination therapy with ribavirin and interferon.
A dry composition as defined in Item ( 7 ) in which the active ingredient is interferon-a.
Use according to Claim 9, wherein the natural human interferon-a is human lymphoblastoid interferon.
Usage An immune response modifier . It stimulates the production of interferon-a.
Current therapies for hepatitis C include interferon-a ( INF a ) and combination therapy with ribavirin and interferon.
Agonists of TLR-7 are immunostimulants and induce the production of endogenous interferon-a in vivo.
The only anti-HCV therapies currently available are interferon-a, interferon-a / ribavirin combination, and pegylated interferon-a.
